Related Experiment Video
Updated: Aug 9, 2026
10:13
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
Do CD4+ CD25+ immunoregulatory T cells hinder tumor immunotherapy?
Paul Andrew Antony1, Nicholas P Restifo
1Surgery Branch, National Cancer Institute, Building 10, Room 2B42, 9000 Rockville Pike, Bethesda, MD 20892, USA. paul_antony@nih.gov
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|May 10, 2002
Summary
Immunoregulatory T cells (Treg) are crucial in controlling immune responses. While targeting Treg function offers therapeutic potential, overcoming tumor-induced immunosuppression requires a deeper understanding of Treg cell biology.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- The concept of T regulatory cells (Treg) influencing immune responses is regaining prominence in immunology.
- Research in genetically modified mice is elucidating the molecular mechanisms of CD4+CD25+ T cells (Treg/Th3/Tr1).
Discussion:
- The glucocorticoid-induced tumor necrosis factor receptor family-related gene (GITR, TNFRSF18) on Tregs presents potential therapeutic targets.
- Blocking the TRANCE and RANK signaling pathway is another potential immunotherapeutic strategy.
- However, experimental models suggest that merely inhibiting Treg function is insufficient for managing established tumors.
Key Insights:
- T regulatory cells play a significant role in immune regulation.
- GITR and the TRANCE/RANK pathway are key molecular players in Treg function.
- Eliminating Treg function alone does not resolve tumor-induced immunosuppression.
Outlook:
- Future immunotherapies must leverage the understanding of Treg cell function to combat established tumors.
- Developing strategies to overcome immunosuppression is critical for effective cancer treatment.
- Further research into Treg cell mechanisms will unlock novel therapeutic interventions.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.